We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Rectal Device Enables Easy Medication Administration

By HospiMedica International staff writers
Posted on 25 Feb 2014
A rectal device offers a discrete and comfortable route for giving drugs and liquids, particularly for patients with serious or terminal illness who often lose the ability to swallow. More...


The Macy Catheter is a Silicone-based disposable device, which once placed by a clinician, rests on a patient's leg or abdomen where it is easily accessible for repeat administration of liquids and medications. The device is comprised of a dual port, dual lumen, ballooned tube that is inserted in the rectum until just past the rectal sphincter, where the retention balloon is inflated (via the balloon inflation port) to hold the device in place.

The medication port is specifically designed to be compatible only with oral and enteral connectors, reducing the probability of connection errors. The medication port also features a valve to prevent leakage, and it is designed to be non-clogging. The Macy Catheter is designed to expel with defecation, since it is smaller and softer than typical stool in the rectum, or it can be easily removed prior to a patient’s bowel movement. The Macy Catheter is a product of Hospi (Newark, CA, USA), and has been approved by the US Food and Drug Administration (FDA).

“Rectal administration is a fast, safe and highly effective route of delivery for many medications, especially those used for management of symptoms at the end of life; however, it is often under-utilized in hospice due to the discomfort and embarrassment associated with suppository administration,” said Brad Macy, RN, inventor of the Macy Catheter and co-founder of Hospi. “The Macy Catheter transforms rectal delivery of medication by providing a comfortable and discreet way to administer ongoing medications and liquids without repeated invasion of privacy and suppository administration.”

Although initially the Macy Catheter is intended to be used primarily to manage symptoms for the approximately 1.65 million patients in US hospices each year, the company sees broad applicability for the device whenever a patient has a compromised oral route, such as due to severe nausea and vomiting. Additional relevant market segments include palliative care, home health, skilled nursing, and acute care.

Related Links:

Hospi



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.